Simon Ducharme, MD, FRCP(C)

Simon Ducharme, MD, FRCP(C)
Hospital title: 
Neuropsychiatrist
Location: 
Neuropsychiatry
Group: 
BIC Core Faculty
Biography: 

Dr. Simon Ducharme is a neuropsychiatrist and a clinician-scientist at The Neuro and the Douglas Mental Health University Institute. He has a medical degree from the Université de Montréal and a Masters from McGill University. He completed his residency in Psychiatry at McGill in 2012, and a fellowship in Behavioral Neurology and Neuropsychiatry at Harvard University in 2014. He is specialized in frontotemporal dementia (FTD), and the interface between psychiatric disorders and dementia. His research program uses advanced neuroimaging techniques to develop diagnostic biomarkers for frontotemporal dementia. Dr. Ducharme holds a Junior 2 clinician-scientist award from the FRQS and his research projects are funded by the CIHR, Weston Brain Institute, JPND, Medteq and Prompt-AI. He is in charge of several innovative clinical trials on dementia at The Neuro and he is the author of over 90 scientific articles and 7 book chapters. He is the Montreal site PI of the Genetic Frontotemporal Dementia Initiative study, the FTD team leader of the Canadian Consortium on Neurodegeneration in Aging, and the co-director of the Neuropsychiatric International Consortium for FTD.  Dr. Ducharme is the director of the McGill Division of Geriatric Psychiatry & Neuropsychiatry and the director of the American Neuropsychiatric Association committee on research.  

 

 

 

Selected publications: 

Ducharme S, Pearl-Dowler L, Gossink F, McCarthy J, Lai J, Dickerson BC, Chertkow H, Rapin L, Vijverberg E, Krudop W, Dols A, Pijnenburg Y. The Frontotemporal Dementia versus Primary Psychiatric Disorder (FTD versus PPD) Checklist: A Bedside Clinical Tool to Identify Behavioral Variant FTD in Patients with Late-Onset Behavioral Changes. J Alzheimers Dis. 2019;67(1):113-124. PubMed PMID: 30584146.

Levy JP, Bocti C, Elie D, Paquet N, Soucy JP, Ducharme S. Bifrontal Hypermetabolism on Brain FDG-PET in a Case of C9orf72-Related Behavioral Variant of Frontotemporal Dementia. J Neuropsychiatry Clin Neurosci. 2019 Winter;31(1):92-94. PubMed PMID: 30404533.

Benrimoh D, Pomerleau VJ, Demoustier A, Poulin S, Maltais JR, Brouillette J, Ducharme S. Why We Still Use "Organic Causes": Results From a Survey of Psychiatrists and Residents. J Neuropsychiatry Clin Neurosci. 2019 Winter;31(1):57-64. PubMed PMID: 30305004.

Alhusaini S, Karama S, Nguyen TV, Thiel A, Bernhardt BC, Cox SR, Corley J, Taylor A, Evans AC, Star JM, Bastin ME, Wardlaw JM, Deary IJ, Ducharme S. Association between carotid atheroma and cerebral cortex structure at age 73 years. Ann Neurol. 2018 Oct;84(4):576-587. PubMed PMID: 30179274.

McCarthy J, Collins DL, Ducharme S. Morphometric MRI as a diagnostic biomarker of frontotemporal dementia: A systematic review to determine clinical applicability. Neuroimage Clin. 2018;20:685-696. PubMed PMID: 30218900.

 

 

 

 

 

Research areas: 
Neuroimaging and Neuroinformatics

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

FacebookinstagramtwitterlinkedInyoutube

Back to top